Most Recent
Former deputy premier of NSW John Barilaro considered "harming himself" after videos were posted by YouTuber Jordan Shanks as part of a “vile and particularly racist smear campaign” facilitated by Google, a court has heard.
Journalist Tegan George will add sex discrimination claims against Network Ten to her lawsuit that alleges harassment and bullying by political journalist Peter van Onselen.
The will of "Australia's worst landlord" -- Melbourne businessman Frank Cassar -- was forged in a conspiracy by his widow, daughter and son who feared losing his multimillion dollar business empire after his death, a court has found.
The owner of a Whitsundays resort has been ordered to hand over $430,738 to an employee whose roommate in staff accommodation allegedly urinated on him after a night of drinking.
Global firm Clifford Chance has lured a Corrs Chambers Westgarth litigation partner to meet the increased demand for projects expertise stemming from pandemic-related construction disputes.
A Federal Court judge has criticised "inappropriate" class action reforms pushed by the government, saying the courts have done a “good job” of crafting solutions to deal with issues that arise in the class action regime.
Shadow attorney-general Mark Dreyfus said he watched “in horror” as a bill mandating that funded class actions be registered as managed investment schemes passed through Parliament in 2020 without consultation.
ASIC has asked a Federal Court registrar who previously worked at Herbert Smith Freehills to step down from overseeing remaining costs disputes in its failed case against former Tennis Australia president Steven Healy, who is represented by the Big Six firm.
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a "commercial outcome for a patentee".
A judge has slammed Novartis for putting forward four "overlapping" experts in a dispute with Pharmacor over patents for its MS drug Gilenya and thrown three of those experts out of an upcoming joint conferral, known as a "hot tub".